The Italian pharmacy approved the AstraZeneca coronavirus vaccine for all adults on Saturday, but it is recommended that people over the age of 55 be given an alternative drug.
The AIFA decision will be made the day after the European Union gives a green light to the jab, but the German Vaccine Commission will use it for the elderly in a question about its effectiveness rejected by the company. I did not recommend that.
“AIFA has approved the AstraZeneca vaccine for the prevention of COVID-19 disease in individuals over the age of 18 according to the guidance of the European Medicines Agency,” he said.
However, he pointed out that there is “some uncertainty” about the claim of jab effectiveness in people over the age of 55. This is because the age group was “underexpressed” in the trial.
To support the best use of the vaccine, we recommended “priority use of the AstraZeneca vaccine in subjects aged 18-55 years with more robust evidence, while waiting for further data.”
It encouraged “priority use of messenger RNA vaccines in the elderly and / or more frail subjects.”
So-called mRNA vaccines include Pfizer / BioNTech and Moderna jabs, which are based on new technologies that have not been tested in the real world.
They use an inert fragment of the genetic code from the coronavirus to provoke an immune response in the body that can repel the active virus.
Many of the other vaccines, including Oxford / AstraZeneca, are variants of the method used for influenza jabs based on the killed and harmless virus.
AstraZeneca has previously rejected the German media over the age of 65 questioning the effectiveness of the vaccine.
“The report that the AstraZeneca / Oxford vaccine is as low as 8% in adults over the age of 65 is completely wrong,” the company said in a statement last Monday.
“In November, Lancet Elderly people have a strong immune response to the vaccine, demonstrating that 100% of older people produce spike-specific antibodies after the second dose. ”
Follow the latest news about the outbreak of coronavirus (COVID-19)
© 2021 AFP
Quote: 55 seconds or more (January 30, 2021) An Italian agency cautious about AstraZeneca jab from https: //medicalxpress.com/news/2021-01-italy-agency-cautious-astrazeneca-jab.html Obtained January 30, 2021
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
Italian agency cautious about AstraZeneca jabs for over 55 seconds
Source link Italian agency cautious about AstraZeneca jabs for over 55 seconds